Cellomatics BioSciences Ltd received support from the £20.3m Enabling Innovation ESIF 2014-2020 programme.
Through Enabling Innovation Cellomatics Biosciences received graduate support from Dr Anushuya Tamang, who joined the company in September 2016, in the field of biological research. Following this initial expansion the company now supports five full-time positions, with the graduate support received via Enabling Innovation making up the core of the Cellomatics lab team.
This project is part-funded by the European Regional Development Fund as part of the European Structural and Investment Funds Growth Programme 2014-2020 in England.
The D2N2 Technical Assistance Team members for European Structural and Investment Funds (ESIF)